Background: Knowledge of HIV status of a TB patient is critical from both patient and public health point of view. Early HIV diagnosis among TB patients could serve as an entry point for HIV care and treatment. Surveillance of HIV among TB patients has been recognized to be important as the HIV epidemic continues to fuel TB epidemics. Hence, this study was conducted with an objective to assess the socio-demographic profi le and the prevalence of HIV among TB patients. Methodology: Cross sectional study was carried out in eight DOTS cum DMCs of Delhi. Data was collected from January 2012 to December 2012. Registered TB patients (new and retreatment) were interviewed on a predesigned questionnaire at the end of fi ve months of treatment. Results: In 2012, out of the total 552 TB patients interviewed, 524 (94.9%) had been tested for HIV by the end of fi fth month of their TB treatment. In them, 13 patients (2.4%) were HIV positive. All of them had been initiated on ART and CPT during continuation phase of TB treatment. In present study no variable was found to be signifi cantly associated with HIV status except number family member and patients on retreatment category. Conclusions: The prevalence of HIV infection in TB patients in current study was (2.4%) substantially lower than reported in studies from other states. If HIV testing done by all TB patients then routine reporting of HIV status for all TB patients would provide even better information on which to base future planning.
INTRODUCTION
Tuberculosis (TB) is the commonest and earliest opportunistic infection affecting Human Immunodefi ciency Virus (HIV) patients in India. Out of the estimated 1.85 million TB cases occurring annually, approximately 5.2% (>96,000 persons) of them are HIV infected. 1 Although the countrywide prevalence remains less than 1% (0.91%) in general population, there is wide variation in prevalence of HIV infection among TB patients in different states of India ranging from 1% to 13.8% while average rate is 5.2%. 2, 3 For Indians infected with HIV, the risk of developing TB increases to 50-60%. 4, 5 Knowledge of HIV status of a TB patient is critical from both patient and public health point of view.
Detection of HIV infection among TB patients offers the opportunity to deliver prompt HIV care, such as Cotrimoxazole Prophylaxis and Antiretroviral Treatment, which can reduce suffering and death. 2 In Delhi, out of total registered TB patients in 2010, only 58% patient knew their HIV status despite HIV testing provided free of cost by the NACP (National AIDS Control Programme). Among those tested, 2% were HIV positive. 6 The prevalence of HIV among TB patients could be more, because 42% of TB patients are reported to be unaware of their HIV status and other reason being high rate of immigration from other states. Surveillance of HIV among TB patients has been recognized to be important as the HIV epidemic continues to fuel TB epidemics. In many countries, HIV prevalence among TB patients is a sensitive indicator of the spread of HIV into the general population. 7 Knowledge of a person's HIV status also provides the opportunity to administer prophylaxis for opportunistic infections and thereby reduces morbidity and mortality. 8 New cross referral strategy was formulated in Delhi by RNTCP and SACS to detect and treat HIV in TB patients. 9 This provides opportunity to detect true prevalence of HIV in TB patients. Programmatic planning requires the availability of up-to-date data on HIV prevalence among different populations of TB patients. However, there is paucity of studies about the socio demographic determinants of HIV among TB patients in Delhi. Hence, this study was conducted with an objective to assess the sociodemographic profi le and the prevalence of HIV among TB patients in Delhi.
Prevalence and socio-demographic correlates of HIV among Tuberculosis patients of DOTS centre in Delhi

MATERIALS AND METHODS
This was a cross sectional study carried out at six DOTS cum Designated Microscopy Centres under Chest Clinic of Lok Nayak Hospital, New Delhi and two DOTS cum Designated Microscopy Centers located in rural area, one at Rural Health Training Centre (R.H.T.C), Barwala and other at Maharaishi Valmiki Hospital (M.V.H.) Pooth Khurd., The study population consisted of all patients with TB registered for DOTS treatment under RNTCP in selected centres. Patients who have completed fi ve months of DOTS therapy were included in the study. Patient with 'known HIV status' (defi ned as any prior positive test result or as a negative result for a test performed within six months prior to diagnosis of TB) and children < 2 years were excluded from the study. Only those TB patients whose HIV status was not known at the time of TB diagnosis were included in the analysis to draw the true prevalence of HIV infection among TB patients. Data was collected, over a period of one year from January to December 2012. The primary outcome variable was prevalence of HIV at the end of fi ve month of anti-TB treatment. It was assumed that patients who did not get tested for HIV at the end fi ve month of treatment, then it was unlikely that he/she will get himself/herself tested in future as well. Hence, in the present study, the time limit for defi ning the outcome variable was the end of fi ve months. At 95% confi dence interval and taking the prevalence of non-uptake of HIV testing in TB patients as 43% (According to 2010 RNTCP performance report of Delhi), with an allowable error of 10%, total sample size was calculated to be 530. A pretested semi-structured questionnaire prepared in both English and Hindi was used to interview registered TB patients to fi nd out prevalence of HIV infection and its socio demographic determinants. Sample was taken from each centre proportionately according to patients registered in the previous year. Extra subjects were included for those who had died or defaulted before the end of fi ve month. Information was collected from the TB treatment card for those who had died and defaulted. The subjects were interviewed after taking informed consent from patients and from parents (patient were 15 years) The information collected from patients were verifi ed and co-related with TB treatment card available at DOTS clinic. The investigator interviewed registered TB patients (both pulmonary as well as extra-pulmonary) at the end of 5 month of DOTS treatment in both category 1 and category 2 patients and in case of children their parents were interviewed. The questionnaire included items on socio-demographic profi le such as age, sex, religion, marital status, per capita income, education and occupation.
Data was analyzed using SPSS software (version 16.0). Data was expressed in terms of mean + SD and percentages. For qualitative data, chi-square or Fischer exact test was used to observe the difference between the proportions. P value < 0.05 was considered signifi cant.
A written informed consent was taken from all the study subjects and in case of children, from their parents. The option to opt out of the study was kept open without any clause. Confi dentiality was ensured and the collected data has been used for research purpose only. Ethical approval from institutional review board was obtained.
RESULTS
A total of 552 study subjects were thus included for analysis. Out of 552 patients, 24 died/defaulters before fi ve month of treatment leaving 528. Data was collected of those died and defaulted from the TB treatment card from the DOTS centre (age, sex, religion, diagnosis of TB, and treatment category). For other variables, we took 528 as sample for analysis.
Socio demographic characteristics of study subjects
The mean age of the study subjects was 29.35 ± 14.8 years. 199 (36.1%) subjects were in the age group of 15-24 years. More than half (52%) of study subjects were males, Hindu (58%), literate (77.5%), unemployed (53.6%), including 76 (26.8%) housewives. 75.2% belonged to lower socio economic class, with a monthly per capita income of less than 2055 rupees (Table 1) .
Of the total 552 subjects, there were 320 (58.0%) pulmonary TB cases and 232 (42.0%) extra pulmonary TB cases. 9 (1.6%) had died and 15 (2.7%) had defaulted before completing 5 months of treatment. Among 320 pulmonary TB cases, 272 (85.0%) were smear positive and 48 (15.0%) were smear negative (Table 2) .
Of the total subjects, 382 (69.2%) were under category I while 170 (30.8%) were in category II regimen. 62 (73.8%) subjects in category I and 22 (26.2%) in category II belonged to rural area and 320 (68.4%) in category I and 148 (31.6%) in category 2 belonged to urban area.
Out of 552 study subjects, 28 (4.1%) subjects not had undergone HIV testing leaving 524 for further analysis. Out of 28 subjects, 15 subjects were died/defaulter before end of fi ve months. HIV status was known for 524 subjects of which 13 (2.4%) were HIV positive. Off the 524 subjects, 13 subjects were died and defaulter. Hence for some variables, the total numbers of subjects were taken as 515 because other data was not available.
Prevalence of HIV among TB patients were found to be 2.4%. Prevalence of HIV in rural area (4.1%) was higher than urban area (2.2%) but the difference was not signifi cant (Table 3 ). The HIV positive cases were more among males (3.6%) as compared to females (1.2%) but the difference was not signifi cant. Majority of HIV positive cases belonged to age group 15-44 years (92.3%). The HIV positivity rates were higher among married (69.2%), Hindus (84.6%) and among lower socio-economic class (83.3%). The signifi cant difference was observed only for number of family member variable. Maximum numbers of HIV positive cases were observed in patients with 1-2 family members. 
DISCUSSION
This study provides the information regarding prevalence of HIV infection and its socio demographic determinants among Tuberculosis patients. Study reveal a very high uptake of HIV testing (94.9%) among tuberculosis patients, it may be because of HIV uptake at the end of fi ve month was the outcome variable we consider for the study titled "Impact of new strategy on provider initiated HIV testing among Tuberculosis patients in Delhi" (Soyam V C et al., manuscript submitted in AIDS Care). The present study demonstrated that HIV prevalence (newly diagnosed HIV) among TB patients at DOTS centre in 2012 to 2013 was 2.4% (13/524) at the end of fi ve month of tuberculosis treatment. From above fi nding it is clear that TB patients are an effi cient source for HIV case-fi nding through this referral strategy of TB-HIV intensifi ed package in India. If HIV testing uptake is high, routine reporting of HIV status for all TB patients would provide even better information on which to base future planning. 2 According to RNTCP annual report 2012, Proportion of TB patients known to be HIV infected among tested was 2% consistent with present study. 10 In a study from India it was found that HIV prevalence among TB patients was 9.0% in the highest prevalence states, 2.9% in the other states, and 4.9% overall.
11 Present [13] [14] [15] [16] From above data it is clearly evident that HIV prevalence among TB patients is increased from 1995 to 2005. However present study found lower prevalence of HIV in TB patients than study conducted by Sharma SK et al and Piramanayagam P et al. 15, 16 This high prevalence of HIV infection in TB patients in Delhi is because of these studies conducted among adult patients and in tertiary care teaching hospitals. However fi ndings (2.4%) in present study support the current study conducted in Delhi from May 2012 to Jan 2013 by Gupta et al shows 92.2% TB patients referred and tested in ICTC of which 1.6% TB patients were HIV positive. 9 As evident from above, it is clear that the prevalence of HIV in TB patients has started decreasing in Delhi.
It was found that HIV prevalence rate among TB patients was more in rural area (4.1%) as compared to urban area (2.2%). This is probably related to selection of area, the area which was selected for present study was Bawana industrial area were immigration from other state is very high that might be reason for high HIV prevalence in rural area. Study from Jammu and Kashmir also showed rural dominance in the prevalence of HIV among pulmonary tuberculosis cases similar to current study. 17 In the present study, majority of the co-infected cases were in the age group of 18-45 years (3.2%). This data suggests that it is better to target TB patients aged between 18 and 45 years for HIV prevention, as 92.3% of the cases were found in this age group. This is a sexually active group in which both TB and HIV prevail the most. 18 Some other studies also reported similar fi ndings that TB-HIV co-infection was more among sexually active age group. [19] [20] [21] Sentinel surveillance study conducted in Delhi by Jain SK et al in 1997-98 suggested a higher risk of HIV co-infection present among males suffering from tuberculosis which is consistent with the present study.
14 In addition to this, a study done at national level across all districts in India, HIV sero-prevalence in TB patients was highest in the groups aged 25-34 years (11.0%) and 35-44 years (10.6%). HIV sero-prevalence was higher among male TB patients than among female TB patients (8.4% vs. 5.6%, RR 1.28, 95% CI 1.04-1.59). 2 In present study no variable was found to be signifi cantly associated with HIV status except number of family member. It was found that those who are staying alone or staying with one person had higher risk of getting HIV infection. However, it may be because of HIV and TB infection stigma, family members were not staying with the patients.
Present study reported higher prevalence of HIV among pulmonary smear negative (4.3%) and extra pulmonary TB (3.2%) patients. HIV prevalence among pulmonary TB patients was 1.6% in present study which is higher than fi ndings reported from China of 0.5%. 22 HIV positivity rate was more among TB patients who were taking category II treatment (4.5%) as compared to category I treatment (1.6%) and this difference was found to be signifi cant (p<0.05).
This study has considerable strengths such as random selection of participants from DOTS centers from both urban and rural area of Delhi. The information was obtained directly from TB patients and also cross checked in TB treatment card.
Limitations
MDR Tuberculosis patients were not included due to lack of resources. Only two DOTS centre from rural area come under the fi eld practice area of community medicine department were included. The study area was selected according to convenience. We also not elicited any risk factor associated with HIV prevalence such as heterosexual relations with multiple partners, b) intravenous drug abuse and c) presence of concomitant STDs.
CONCLUSIONS
The prevalence of HIV infection among Tuberculosis patients in this study was 2.4% which is substantially lower than other states. Greater focus of health intervention should be required on reproductive age group and in area in which high immigration and overcrowding present. It is imperative that physician and DOTS provider taking care of TB patients should aggressively send category II patients for HIV testing.
